Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Clement

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Lancet Regional Health. Europe|December 15, 2025
Pediatric thyroid cancer in Europe: time to act and rethink careSarah C Clement, Hanneke M van Santen
Nederlands Tijdschrift Voor Geneeskunde|February 15, 2013
[A newborn with tachypnea]Suzanne M Pronk, Sarah C Clement, Olivier Weijer
Endocrine Connections|October 14, 2022
The effect of surveillance for differentiated thyroid carcinoma in childhood cancer survivors on survival rates: a decision-tree-based analysisAlexander Heinzel, Dirk Müller, Hanneke M van Santen, et al.
Annals of Nuclear Medicine|May 2, 2022
Thyroid function after diagnostic <sup>123</sup>I-metaiodobenzylguanidine in children with neuroblastic tumorsSarah C Clement, Godelieve A M Tytgat, A S Paul van Trotsenburg, et al.
European Journal of Endocrinology|May 26, 2020
Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national studySarah C Clement, Chantal A Lebbink, Mariëlle S Klein Hesselink, et al.
Pediatric Blood & Cancer|August 19, 2014
High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programsSarah C Clement, Antoinette Y N Schouten-van Meeteren, Leontien C M Kremer, et al.
European Journal of Endocrinology|June 9, 2020
Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivorsHanneke M van Santen, Erik K Alexander, Scott A Rivkees, et al.
Journal of Neuroendocrinology|July 13, 2023
Elevated IGF-1 concentrations in children with low grade glioma: A descriptive analysis in a retrospective national cohortJiska van Schaik, Ichelle M A A van Roessel, Iris D Bos, et al.
Thyroid : Official Journal of the American Thyroid Association|November 7, 2025
Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi StudyDaniël J van de Berg, Menno R Vriens, Hanneke M van Santen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter StudySarah C Clement, Antoinette Y N Schouten-van Meeteren, Annemieke M Boot, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Lancet Regional Health. Europe|December 15, 2025
Pediatric thyroid cancer in Europe: time to act and rethink careSarah C Clement, Hanneke M van Santen
Nederlands Tijdschrift Voor Geneeskunde|February 15, 2013
[A newborn with tachypnea]Suzanne M Pronk, Sarah C Clement, Olivier Weijer
Endocrine Connections|October 14, 2022
The effect of surveillance for differentiated thyroid carcinoma in childhood cancer survivors on survival rates: a decision-tree-based analysisAlexander Heinzel, Dirk Müller, Hanneke M van Santen, et al.
Annals of Nuclear Medicine|May 2, 2022
Thyroid function after diagnostic <sup>123</sup>I-metaiodobenzylguanidine in children with neuroblastic tumorsSarah C Clement, Godelieve A M Tytgat, A S Paul van Trotsenburg, et al.
European Journal of Endocrinology|May 26, 2020
Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national studySarah C Clement, Chantal A Lebbink, Mariëlle S Klein Hesselink, et al.
Pediatric Blood & Cancer|August 19, 2014
High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programsSarah C Clement, Antoinette Y N Schouten-van Meeteren, Leontien C M Kremer, et al.
European Journal of Endocrinology|June 9, 2020
Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivorsHanneke M van Santen, Erik K Alexander, Scott A Rivkees, et al.
Journal of Neuroendocrinology|July 13, 2023
Elevated IGF-1 concentrations in children with low grade glioma: A descriptive analysis in a retrospective national cohortJiska van Schaik, Ichelle M A A van Roessel, Iris D Bos, et al.
Thyroid : Official Journal of the American Thyroid Association|November 7, 2025
Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi StudyDaniël J van de Berg, Menno R Vriens, Hanneke M van Santen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter StudySarah C Clement, Antoinette Y N Schouten-van Meeteren, Annemieke M Boot, et al.
Pageof 2